TriangleFOR PATIENTS · SOURCE READING
Targeted therapy
Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Context: Treatment Option Overview / The following types of treatment are used:
Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells.
Source links and citations
Tyrosine kinase inhibitor (TKI) therapy: TKI therapy blocks signals that cancer cells need to grow. Ruxolitinib is used to treat polycythemia vera and certain types of myelofibrosis.
Source links and citations
Learn more at Drugs Approved for Myeloproliferative Neoplasms.
Source links and citations
Other types of targeted therapies are being studied in clinical trials.
Preserved source evidence · Independent clinical review pending · Not medical advice